Serial Lavage and Drainage for Punctured Lung
(HTXDLYLAVGE Trial)
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial examines how different chest tube sizes and daily cleaning techniques (irrigations) affect individuals with a punctured lung, specifically those with acute hemothorax (HTX), where blood collects between the lung and chest wall. The study compares two chest tube methods, including the serial lavage and drainage technique, to determine which is more effective for lung healing, recovery time, and patient comfort. Participants should be stable after a traumatic lung injury, have a moderate to large amount of blood in the chest, and require a chest tube for drainage. This trial aims to improve treatments for lung injuries, making recovery safer and more comfortable. As an unphased trial, it offers participants the opportunity to contribute to pioneering research that could enhance future treatment options.
Do I have to stop taking my current medications for the trial?
The trial information does not specify whether you need to stop taking your current medications.
What prior data suggests that this technique is safe for treating punctured lungs?
Research shows that both open tube thoracostomy and percutaneous catheter methods are commonly used to manage fluid or air in the chest. Studies have found that tube thoracostomy, which involves placing a tube into the chest, is widely used. However, complications such as infection or tube displacement can occur.
Research suggests that the percutaneous catheter is as effective as larger chest tubes for fluid drainage. Major complications are rare, though some patients may experience fluid recurrence or mild pain after the procedure.
In summary, both treatments are generally safe, but like any procedure, they carry some risks. These risks are usually low and similar for both methods.12345Why are researchers excited about this trial?
Researchers are excited about these new lavage and drainage methods for punctured lungs because they offer innovative approaches to managing the condition. Unlike the standard of care, which typically involves simple tube thoracostomy without daily lavage, these treatments incorporate daily lavage, potentially reducing infection risk and improving lung re-expansion. The Open 28 Fr Tube Thoracostomy provides a larger drainage channel, while the Percutaneous 14-Fr Catheter offers a less invasive option. Both methods aim to enhance recovery outcomes by improving fluid removal and promoting quicker healing.
What evidence suggests that this trial's treatments could be effective for punctured lung?
This trial will compare two methods for treating traumatic hemothorax: an open 28 Fr tube thoracostomy with daily lavage and drainage, and a percutaneous 14-Fr catheter with daily lavage and drainage. Research has shown that both open tube thoracostomy and using a small tube with daily washing and drainage effectively treat traumatic hemothorax, a condition where blood collects in the chest. Studies have found that a small tube, called a 14-Fr percutaneous catheter, performs as well as a larger chest tube in removing blood from the chest. Both methods successfully clear blood and air without causing additional complications. These treatments help the lung expand and improve breathing. Initial findings suggest that daily chest washing can enhance drainage and reduce hospital stays. Overall, both methods are promising options for managing this condition.36789
Who Is on the Research Team?
Jeremy Cannon, MD
Principal Investigator
University of Pennsylvania
Are You a Good Fit for This Trial?
This trial is for stable trauma patients who have an acute hemothorax (blood in the chest from a punctured or collapsed lung) and need a chest tube. Specific details about inclusion and exclusion criteria are not provided, but typically participants must meet certain health standards to be eligible.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants receive either a 28Fr or 14Fr chest tube with daily lavage and drainage
Follow-up
Participants are monitored for safety and effectiveness after treatment, including assessment of hemothorax volume and complications
Extension
Participants may be monitored for additional interventions and patient-reported outcomes
What Are the Treatments Tested in This Trial?
Interventions
- Serial Lavage and Drainage
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of Pennsylvania
Lead Sponsor
CLR Medical
Collaborator